The case underscores the importance of systematic, guideline-based assessment to differentiate benign lesions from potential secondary malignancies in this high-risk group. Although the lesion in this report was benign, both prior mediastinal radiation and the later-confirmed BRCA1 mutation independently elevate lifetime breast-cancer risk. This evidence concerns the gene BRCA1 and breast cancer.